Eli Lilly and Company
LLY · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $65.2B | $45.0B | +44.7% |
| Operating income | $26.3B | $12.9B | +104% |
| Net income | $20.6B | $10.6B | +94.9% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Oct 29, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $24.4B | $17.6B | +38.6% |
| Operating income | $8.41B | $7.23B | +16.2% |
| Net income | $6.45B | $5.58B | +15.5% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Lilly's revenue in FY2025?
- $65.2B in FY2025 (Fiscal year ended Dec 31, 2025), +44.7% vs $45.0B a year earlier, per its 10-K filed Feb 2026.
- Was Lilly profitable in FY2025?
- Yes: net income was $20.6B and operating income $26.3B in FY2025.
- What was Lilly's revenue in Q3 2026?
- $24.4B (+38.6% vs a year earlier), per its Form 10-Q filed Oct 29, 2026.